Biomarin: Challanges Mount, But Sale Rumours Make For A Risky "Buy" Call
BioMarin Pharmaceutical(BMRN) Seeking Alpha·2024-11-22 04:00
If you like what you have just read and want to receive at least 4 exclusive stock tips every week focused on Pharma, Biotech and Healthcare, then join me at my marketplace channel, Haggerston BioHealth . Invest alongside the model portfolio or simply access the investment bank-grade financial models and research. I hope to see you there.I last covered BioMarin (NASDAQ: BMRN ) in a note for Seeking Alpha back in June last year, just ahead of the Prescription Drug User fee Act ("PDUFA") date for its hemophil ...